Can you take Influenza virus vaccine, h1n1, live with Vimkunya?
1 drug interaction and 1 additional warning found for the following 2 drugs:
- influenza virus vaccine, h1n1, live
- Vimkunya (chikungunya vaccine, recombinant (cvx 329))
Drug interactions
Minor drug interactions
Minor:
influenza virus vaccine, H1N1, live chikungunya vaccine, recombinant (cvx 329)
Applies to: influenza virus vaccine, h1n1, live and Vimkunya (chikungunya vaccine, recombinant (cvx 329))
Information for this minor interaction is available on the professional version.
Food/lifestyle interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Disease interactions
1 potential interaction Applies to: 1 condition, including Immunodeficiency.
Immunodeficiency
Moderate:
Vimkunya
The chikungunya vaccine, recombinant (cvx 329) in Vimkunya has a moderate potential interaction with Immunodeficiency.
The expected serum antibody responses may not be obtained when vaccines and/or toxoids are administered to patients with primary or acquired immunodeficiency, including those with severe combined immunodeficiency, hypogammaglobulinemia or agammaglobulinemia, HIV infection, altered immune states (due to diseases such as leukemia, lymphoma, or generalized malignancy), or immunosuppression due to drug or other treatments (e.g., corticosteroids, alkylating agents, antimetabolites, or radiation).
More resources
influenza virus vaccine, h1n1, live
A total of 445 drugs are known to interact with influenza virus vaccine, h1n1, live.
- Influenza virus vaccine, h1n1, live is in the drug class viral vaccines.
- Influenza virus vaccine, h1n1, live is used to treat the following conditions:
Vimkunya
A total of 340 drugs are known to interact with Vimkunya.
- Vimkunya is in the drug class viral vaccines.
- Vimkunya is used to treat Chikungunya Disease Prevention.
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.